Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666211 · ClinicalTrials.gov registry record · Phase 3
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
A Phase 3 study of Pain and Lymphoma, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 98
- Enrollment target
- 11
- Study locations
NCT00666211: Completed Phase 3 study of Pain and Lymphoma, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00666211 is a Phase 3 study of Pain and Lymphoma that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 98 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower). The trial reports 11 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666211, a Phase 3 study of Pain and Lymphoma, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 98 participants
- Enrollment target
- 11
- Study locations
Study Summary
RATIONALE: An Opioid Titration Order Sheet that allows healthcare providers to adjust the dose and schedule of pain medication may help improve pain treatment for patients with cancer. It is not yet known whether the use of an Opioid Titration Order Sheet is more effective than standard care in treating pain caused by cancer. PURPOSE: This randomized phase III trial is studying an Opioid Titration Order Sheet to see how well it works compared with standard care in treating patients with cancer pain.
Primary Outcome
Patients in each arm will each have 9 measures: daily scores averaged over 1 week with baseline to week 8: 1. Average daily pain intensity 0 (no pain) to 10 (worst) scale 2. Worst daily pain intensity 0 (no pain) to 10 (worst) scale
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
- OTHER Titrated pain management
Study Locations (11)
Tennessee
- Erlanger Health System - Chattanooga
- Tennessee Plateau Oncology - Crossville
- Center for Biomedical Research - Knoxville
- The Jones Clinic - Memphis
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Meharry Medical College - Nashville
- Veterans Affairs Medical Center - Nashville - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Kentucky
- Jennie Stuart Medical Center - Hopkinsville
- Mitchell Memorial Cancer Center at Owensboro Medical Health System - Owensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
What the finished NCT00666211 record still lists
NCT00666211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower).
The record links to 10 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00666211 lists 11 locations in 2 states (Tennessee, Kentucky).
Frequently Asked Questions
What is clinical trial NCT00666211 about?
NCT00666211 is a clinical study titled "Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain". RATIONALE: An Opioid Titration Order Sheet that allows healthcare providers to adjust the dose and schedule of pain medication may help improve pain treatment for patients with cancer. It is not yet known whether the use of an Opioid Titration Order Sheet is more effective than standard care in trea...
What is the current status of trial NCT00666211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2005-05. Estimated completion is 2010-05.
What conditions does trial NCT00666211 study?
This clinical trial studies the following conditions: Pain, Lymphoma, Leukemia, Myelodysplastic Syndromes, Brain and Central Nervous System Tumors.
What interventions are being tested in trial NCT00666211?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), Titrated pain management (OTHER).
Who is sponsoring clinical trial NCT00666211?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00666211 being conducted?
This trial has 11 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00666211's enrollment target sits among peer trials
98 176th of 374 higher than 198 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia